These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12658270)

  • 21. Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity.
    Umeshappa CS; Mbongue J; Singha S; Mohapatra S; Yamanouchi J; Lee JA; Nanjundappa RH; Shao K; Christen U; Yang Y; Ellestad KK; Santamaria P
    J Clin Invest; 2020 Apr; 130(4):1823-1829. PubMed ID: 32125290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
    Lo J; Xia CQ; Peng R; Clare-Salzler MJ
    J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic T lymphocytes and autoimmunity.
    Blanco P; Viallard JF; Pellegrin JL; Moreau JF
    Curr Opin Rheumatol; 2005 Nov; 17(6):731-4. PubMed ID: 16224251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells.
    McPherson SW; Heuss ND; Pierson MJ; Gregerson DS
    J Neuroinflammation; 2014 Dec; 11():205. PubMed ID: 25498509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reactive T cells: suppressing the suppressors.
    Becker JC; thor Straten P; Andersen MH
    Cancer Immunol Immunother; 2014 Apr; 63(4):313-9. PubMed ID: 24368340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.
    Serra P; Santamaria P
    Eur J Immunol; 2018 May; 48(5):751-756. PubMed ID: 29427438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.
    von Boehmer H; Daniel C
    Nat Rev Drug Discov; 2013 Jan; 12(1):51-63. PubMed ID: 23274471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent miscarriage and autoimmunity.
    Bansal AS; Bajardeen B; Shehata H; Thum MY
    Expert Rev Clin Immunol; 2011 Jan; 7(1):37-44. PubMed ID: 21162648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance to islet autoantigens in type 1 diabetes.
    Bach JF; Chatenoud L
    Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells.
    Read S; Hogan TV; Zwar TD; Gleeson PA; Van Driel IR
    Gastroenterology; 2007 Aug; 133(2):547-58. PubMed ID: 17603058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of Antigen-Specific Tolerance in T Cell Mediated Diseases.
    Passerini L; Gregori S
    Front Immunol; 2020; 11():2194. PubMed ID: 33133064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.
    Raverdeau M; Christofi M; Malara A; Wilk MM; Misiak A; Kuffova L; Yu T; McGinley AM; Quinn SM; Massilamany C; Reddy J; Forrester JV; Mills KH
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30894405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function.
    Samy ET; Setiady YY; Ohno K; Pramoonjago P; Sharp C; Tung KS
    Immunol Rev; 2006 Aug; 212():170-84. PubMed ID: 16903914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell receptor crossreactivity and autoimmune disease.
    Cantor H
    Adv Immunol; 2000; 75():209-33. PubMed ID: 10879285
    [No Abstract]   [Full Text] [Related]  

  • 37. Generation of acetylcholine receptor-specific human T cell lines using heterobifunctional antibody-targeted antigen presentation.
    Wang D; Nicolle MW
    J Neuroimmunol; 1999 Sep; 99(1):114-21. PubMed ID: 10496184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific TGF-β-induced regulatory T cells secrete chemokines, regulate T cell trafficking, and suppress ongoing autoimmunity.
    Nguyen TL; Sullivan NL; Ebel M; Teague RM; DiPaolo RJ
    J Immunol; 2011 Aug; 187(4):1745-53. PubMed ID: 21746962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related autoimmunity.
    Vadasz Z; Haj T; Kessel A; Toubi E
    BMC Med; 2013 Apr; 11():94. PubMed ID: 23556986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased endogenous antigen presentation in the periphery enhances susceptibility to inflammation-induced gastric autoimmunity in mice.
    Overall SA; Bourges D; van Driel IR; Gleeson PA
    Eur J Immunol; 2017 Jan; 47(1):155-167. PubMed ID: 27759162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.